MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KYMR made $2,764K in revenue. -$80,953K in net income. Net profit margin of -2928.84%.

Income Overview

Revenue
$2,764K
Net Income
-$80,953K
Net Profit Margin
-2928.84%
EPS
-$0.94
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Collaboration revenue
2,764 11,476 14,444 3,741
Research and development
74,094 78,388 59,946 60,410
General and administrative
17,336 17,645 16,026 15,455
Impairment of long-lived assets
3,855 0 1,231 -
Total operating expenses
95,285 96,033 77,614 75,865
Loss from operations
-92,521 -84,557 -63,170 -72,124
Interest and other income
10,444 8,051 9,443 9,697
Interest and other expense
98 108 63 60
Total other income
10,346 7,943 9,380 9,637
Net loss
-82,175 -76,614 -53,790 -62,487
Unrealized gain on marketable securities
1,222 337 -1,654 4,030
Total comprehensive loss
-80,953 -76,277 -55,445 -58,457
Net loss per share, basic
-0.94 -0.95 -0.72 -0.82
Net loss per share, diluted
-0.94 -0.95 -0.72 -0.82
Weighted average common shares outstanding, basic
87,300,286 80,449,405 -360,661.333 76,125,975
Weighted average common shares outstanding, diluted
87,300,286 80,449,405 -360,661.333 76,125,975
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$80,953K Unrealized gain onmarketable securities$1,222K Interest and other income$10,444K Net loss-$82,175K Total other income$10,346K Interest and otherexpense$98K Loss from operations-$92,521K Collaboration revenue$2,764K Total operatingexpenses$95,285K Impairment of long-livedassets$3,855K General andadministrative$17,336K Research and development$74,094K

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. (KYMR)